PHARMACEUTICAL ADVERTISING TO THE PUBLIC – GAO WEIGHS IN ON THE FDA – WWW GROWTH TOO FAST – PATIENTS SMOTHERING IN DRUG ADS

WWW.CASTMD.COM HAS BEEN HOT Guns TRACKING THIS ONGOING MASSIVE PATIENT BOMBARDMENT. 

NOW YOU TOO CAN READ THE WARNING LETTERS FROM THE FDA SITE.

http://www.fda.gov/cder/warn/warn2006.htm

 http://www.fda.gov/foi/warning.htm

LIKE PREVIOUS CASTMD.COM BLOGS, http://www.castmd.com/?p=86 THIS LEVEL OF MARKETING PLACES RISK ON PATIENTS AND PHYSICIANS THROUGH THE USE OF THE OLD MARKETING PLOYS AND SILENT ADVERTISING - "SUBLIMINAL SUGGESTION."  http://www.castmd.com/?p=79   Annoyed

FDA officials are issuing fewer offense warnings to drug companies for false and misleading advertisements and are taking longer to do it, a congressional report says.

Annual spending on direct-to-consumer drug advertisements at $4.2 billion and growing, the government has limited ability to curb distribution of ads that violate federal rules, according to the report being released Thursday.

From 2002 through 2005, it took the FDA four months on average to draft, approve and send warning letters and other correspondence to companies that were in violation of the rules, government auditors said.

Between 1997 and 2001, before FDA lawyers began reviewing the letters as a matter of policy, it took just two weeks on average to issue the letters. The number of letters fell off by about half between the two time periods.

The GAO also said the FDA lacks an effective way to screen, review and track the more than 10,000 ads and Web sites brought to the agency's attention each year. The amount has doubled in just four years.

(adapted from fxnws/fda/gao)

Leave a Reply

You must be logged in to post a comment.